Cargando…
Cardiovascular Complications of Novel Anti-Cancer Immunotherapy: Old Problems from New Agents?
Many novel anti-cancer therapies have dramatically improved outcomes of various cancer patients. However, it also poses a risk for cardiovascular complications as well. For the novel anti-cancer agent with which physicians does not have enough clinical experiences to determine the characteristics of...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Society of Cardiology
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440999/ https://www.ncbi.nlm.nih.gov/pubmed/32725983 http://dx.doi.org/10.4070/kcj.2020.0158 |